Prevencio Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Prevencio's estimated annual revenue is currently $2M per year.(i)
  • Prevencio's estimated revenue per employee is $183,182

Employee Data

  • Prevencio has 11 Employees.(i)
  • Prevencio grew their employee count by 0% last year.

Prevencio's People

NameTitleEmail/Phone
1
CEO, President, Chief Translational Officer, and Board DirectorReveal Email/Phone
2
President & CEOReveal Email/Phone
3
Chief Commercial Officer (CCO)Reveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Chief Analytics OfficerReveal Email/Phone
6
Chief Financial OfficerReveal Email/Phone
7
VP, Clinical Market DevelopmentReveal Email/Phone
8
Vice-President Clinical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M50%N/AN/A
#2
$0.9M50%N/AN/A
#3
$5.1M3011%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M415%$10.1MN/A
#7
$1.1M1183%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M8100%N/AN/A
Add Company

What Is Prevencio?

Prevencio, Inc., is Revolutionizing Blood Tests For Cardiovascular Disease —Powered by Artificial Intelligence (AI) Prevencio's value  proposition is "Preventing the Preventable — That is, improving patient outcomes and clinical trials through more accurate blood tests for Cardiovascular Disease conditions.   Prevencio utilizes Machine Learning (Artificial Intelligence) + Multi-Proteomic Biomarkers + Proprietary Algorithms to deliver cardiovascular diagnostic & prognostic tests that are significantly more accurate than standard-of-care stress tests, individual biomarkers, genetic markers and clinical risk scores. To learn more visit us at: www.prevenciomed.com

keywords:N/A

N/A

Total Funding

11

Number of Employees

$2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M11-15%N/A
#2
$1.4M12-8%N/A
#3
$2.5M12-8%N/A
#4
$0.6M1233%N/A
#5
$1.3M13-7%N/A